
Leukocare AG (Leukocare) is a clinical-stage biotechnology company, based in Germany. It develops immunomonitoring systems for the treatment of rapid diagnosis of inflammation and tissue damage. The company provides solutions for protein stabilization applied in biopharmaceuticals, vaccines, functionalized medical devices and diagnostics. It can functionalize a wide variety of surfaces including wound dressings, orthopedic implants, catheters, patches, stents, and columns for ex-vivo blood treatment. The company has developed a standardized assay, which measure the concentration of cell-free DNA in patient plasma. Leukocare leverages its comprehensive biofunctional coating expertise in product-focused industry partnerships. Its research and development facilities are present in Frankfurt/Main. The company is ISO 9001 and ISO 13485 certified for its Quality Management System (QMS). Leukocare is headquartered in Munich, Germany.